(Q38472178)

English

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 September 2017

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time (English)

1 reference

Europe PubMed Central

3 September 2017

1 reference

based on heuristic

inferred from title

author name string

A Gratwohl

1

1 reference

Europe PubMed Central

3 September 2017

R Brand

2

1 reference

Europe PubMed Central

3 September 2017

F Frassoni

3

1 reference

Europe PubMed Central

3 September 2017

V Rocha

4

1 reference

Europe PubMed Central

3 September 2017

D Niederwieser

5

1 reference

Europe PubMed Central

3 September 2017

P Reusser

6

1 reference

Europe PubMed Central

3 September 2017

H Einsele

7

1 reference

Europe PubMed Central

3 September 2017

C Cordonnier

8

1 reference

Europe PubMed Central

3 September 2017

Acute and Chronic Leukemia Working Parties

9

1 reference

Europe PubMed Central

3 September 2017

Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

10

1 reference

Europe PubMed Central

3 September 2017

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

3 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

3 September 2017

36

1 reference

Europe PubMed Central

3 September 2017

9

1 reference

Europe PubMed Central

3 September 2017

757-769

1 reference

Europe PubMed Central

3 September 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705140

0 references

Haemopoietic stem-cell transplantation: recent progress and future promise

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Infections following hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Hematopoietic cell transplantation: five decades of progress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Bone-marrow transplantation (second of two parts).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Protective isolation in hemopoietic stem cell transplants: a review of the literature and single institution experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Infectious complications after allogeneic stem cell transplantation: epidemiology and interventional therapy strategies--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Hospital infection control in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Non-myeloablative stem cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

High rate of invasive fungal infections following nonmyeloablative allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

21 January 2018

Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Current trends in hematopoietic stem cell transplantation in Europe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Bacterial complications of transplantation: diagnosis and treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis of infection in patients with aplastic anemia receiving allogeneic marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Smarter rather than stronger treatment of haematological malignancies and non-malignant indications for stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Outbreak of invasive mycoses caused by Paecilomyces lilacinus from a contaminated skin lotion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Stem cell transplantation: supportive care and long-term complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious complications following nonmyeloablative allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Home care for children following haematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705140

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705140

1 reference

Europe PubMed Central

3 September 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38472178&oldid=1761316612"